Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Dolby Laboratories (DLB) Other Operating Expenses (2016 - 2025)

Dolby Laboratories' Other Operating Expenses history spans 16 years, with the latest figure at $91.6 million for Q4 2025.

  • For Q4 2025, Other Operating Expenses fell 3.02% year-over-year to $91.6 million; the TTM value through Dec 2025 reached $357.9 million, up 4.04%, while the annual FY2025 figure was $360.7 million, 7.85% up from the prior year.
  • Other Operating Expenses reached $91.6 million in Q4 2025 per DLB's latest filing, up from $90.5 million in the prior quarter.
  • In the past five years, Other Operating Expenses ranged from a high of $108.1 million in Q3 2023 to a low of $77.5 million in Q2 2024.
  • Average Other Operating Expenses over 4 years is $89.0 million, with a median of $90.0 million recorded in 2024.
  • The largest YoY upside for Other Operating Expenses was 21.5% in 2024 against a maximum downside of 24.11% in 2024.
  • A 4-year view of Other Operating Expenses shows it stood at $82.2 million in 2022, then decreased by 5.49% to $77.7 million in 2023, then increased by 21.5% to $94.4 million in 2024, then dropped by 3.02% to $91.6 million in 2025.
  • Per Business Quant, the three most recent readings for DLB's Other Operating Expenses are $91.6 million (Q4 2025), $90.5 million (Q3 2025), and $86.2 million (Q2 2025).